Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial
- Resource Type
- Article
- Source
- In
Lung Cancer September 2022 171:26-33 - Subject
- Language
- ISSN
- 0169-5002